中华老年多器官疾病杂志
中華老年多器官疾病雜誌
중화노년다기관질병잡지
CHINESE JOURNAL OF MULTIPLE ORGAN DISEASES IN THE ELDERLY
2014年
4期
247-250
,共4页
杨丽霞%田祥全%郭瑞威%叶金善%齐峰
楊麗霞%田祥全%郭瑞威%葉金善%齊峰
양려하%전상전%곽서위%협금선%제봉
冠心病%细胞外基质金属蛋白酶诱导因子%C反应蛋白
冠心病%細胞外基質金屬蛋白酶誘導因子%C反應蛋白
관심병%세포외기질금속단백매유도인자%C반응단백
coronary disease%extracellular matrix metalloproteinase inducer%C-reactive protein
目的:研究冠心病临床类型与细胞外基质金属蛋白酶诱导因子(EMMPRIN)的关系。方法根据临床表现和冠状动脉造影结果,179例患者分成稳定型心绞痛(SAP)35例,不稳定型心绞痛(UAP)76例,急性心肌梗死(AMI)68例,健康对照组30例。流式细胞仪检测患者外周血单个核细胞(PBMCs)表面EMMPRIN的平均荧光强度(MFI);免疫速率法检测血清高敏C反应蛋白(hs-CRP)浓度,分析冠心病组患者EMMPRIN水平与冠状动脉造影Gensini评分的相关性。结果 PBMCs表面EMMPRIN表达在冠心病临床分型中AMI组、UAP组、SAP组明显高于对照组,差异有统计学意义(P<0.05)。病变血管累及支数越多,其表达增加越明显,三支病变>双支病变>单支病变>对照组,差异有统计学意义(P<0.05)。相关性分析显示,PBMCs表面EMMPRIN(MFI)与血清hs-CRP浓度及冠状动脉病变Gensini评分呈正相关。结论 EMMPRIN水平与冠心病临床分型相关。
目的:研究冠心病臨床類型與細胞外基質金屬蛋白酶誘導因子(EMMPRIN)的關繫。方法根據臨床錶現和冠狀動脈造影結果,179例患者分成穩定型心絞痛(SAP)35例,不穩定型心絞痛(UAP)76例,急性心肌梗死(AMI)68例,健康對照組30例。流式細胞儀檢測患者外週血單箇覈細胞(PBMCs)錶麵EMMPRIN的平均熒光彊度(MFI);免疫速率法檢測血清高敏C反應蛋白(hs-CRP)濃度,分析冠心病組患者EMMPRIN水平與冠狀動脈造影Gensini評分的相關性。結果 PBMCs錶麵EMMPRIN錶達在冠心病臨床分型中AMI組、UAP組、SAP組明顯高于對照組,差異有統計學意義(P<0.05)。病變血管纍及支數越多,其錶達增加越明顯,三支病變>雙支病變>單支病變>對照組,差異有統計學意義(P<0.05)。相關性分析顯示,PBMCs錶麵EMMPRIN(MFI)與血清hs-CRP濃度及冠狀動脈病變Gensini評分呈正相關。結論 EMMPRIN水平與冠心病臨床分型相關。
목적:연구관심병림상류형여세포외기질금속단백매유도인자(EMMPRIN)적관계。방법근거림상표현화관상동맥조영결과,179례환자분성은정형심교통(SAP)35례,불은정형심교통(UAP)76례,급성심기경사(AMI)68례,건강대조조30례。류식세포의검측환자외주혈단개핵세포(PBMCs)표면EMMPRIN적평균형광강도(MFI);면역속솔법검측혈청고민C반응단백(hs-CRP)농도,분석관심병조환자EMMPRIN수평여관상동맥조영Gensini평분적상관성。결과 PBMCs표면EMMPRIN표체재관심병림상분형중AMI조、UAP조、SAP조명현고우대조조,차이유통계학의의(P<0.05)。병변혈관루급지수월다,기표체증가월명현,삼지병변>쌍지병변>단지병변>대조조,차이유통계학의의(P<0.05)。상관성분석현시,PBMCs표면EMMPRIN(MFI)여혈청hs-CRP농도급관상동맥병변Gensini평분정정상관。결론 EMMPRIN수평여관심병림상분형상관。
Objective To investigate the relationship of clinical classification of coronary heart diseases (CHD) with the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in peripheral blood mononuclear cells of CHD patients. Methods A total of 179 CHD cases diagnosed by coronary angiography in our department from September 2012 to May 2013 were recruited in this study. They were divided into 3 groups according to the clinical types: stable angina pectoris group (SAP, n=35), unstable angina pectoris group (UAP, n=76), and acute myocardial infarction group (AMI, n=68). Another 30 healthy individuals at the same period served as normal controls. Mean fluorescence intensity (MFI) of EMMPRIN in peripheral blood mononuclear cells (PBMCs) were examined by flow cytometry. Serum level of high-sensitivity C-reactive protein (hs-CRP) was measured with immune velocity assay. The correlation of the expression of EMMPRIN was analyzed with the Gensini scores by coronary angiography. Results The expression of EMMPRIN in PBMCs was significantly higher in AMI, UAP and SAP groups than in the controls (P<0.05). The expression was also positively correlated with the number of involved vessels, which was increased gradually in normal controls, single-vessel, double-vessel, and triple-vessel disease groups sequentially (P<0.05). The EMMPRIN MFI of the PBMCs had positive correlation with the serum level of hs-CRP and Gensini scores in coronary arterial lesion. Conclusion The expression of EMMPRIN is correlated with the clinical classification of CHD.